Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorROCHA, Luiza F.
dc.contributor.authorMARANGONI, Roberta G.
dc.contributor.authorSAMPAIO-BARROS, Percival D.
dc.contributor.authorLEVY-NETO, Mauricio
dc.contributor.authorYOSHINARI, Natalino H.
dc.contributor.authorBONFA, Eloisa
dc.contributor.authorSTEEN, Virginia
dc.contributor.authorKOWALSKI, Sergio C.
dc.date.accessioned2014-09-30T14:38:08Z
dc.date.available2014-09-30T14:38:08Z
dc.date.issued2014
dc.description.abstractThe Scleroderma Health Assessment Questionnaire (SHAQ) is a feasible multisystem specific tool that has been extensively used as an additional assessment for systemic sclerosis (SSc). The aim of this study is to cross-culturally adapt and validate the Brazilian version of the SHAQ. Construct validity was assessed based on the correlations between SHAQ and both the Medical Outcomes Survey Short Form 36 version 2 (SF-36v2 (TM)) and the Health Assessment Questionnaire Disability Index (HAQ-DI). The correlation between the SHAQ and disease severity was assessed by Spearman's correlation coefficient. The reproducibility of the SHAQ was evaluated by the intraclass correlation coefficient (ICC). Among the 151 consecutive outpatients evaluated, 59 % had limited SSc subtype. The overall disease severity visual analog scale (VAS) of the SHAQ was statistically significantly correlated to HAQ-DI, pain VAS, and the SF-36v2 (TM) physical component summary score (r = 0.595, r = 0.612, and r = -0.582, respectively; p < 0.001). Further analysis of all SF-36v2 (TM) components revealed statistically significant correlations between overall disease severity VAS and bodily pain (r = -0.621, p < 0.001), vitality (r = -0.544, p < 0.001), physical function (r = -0.510, p < 0.001), and role limitation-physical dimensions (r = -0.505, p < 0.001). Moreover, digestive, pulmonary, and overall disease severity VASs were statistically significantly correlated to the number of organs involved (r = 0.178, p = 0.029; r = 0.214, p = 0.008; r = 0.282, p < 0.001). We also demonstrated high reproducibility for SHAQ (ICC = 0.757, 95 % confidence interval = 0.636-0.842). The Brazilian version of the SHAQ demonstrated both construct and discriminant validities as well as good reproducibility.
dc.description.indexMEDLINE
dc.identifier.citationCLINICAL RHEUMATOLOGY, v.33, n.5, p.699-706, 2014
dc.identifier.doi10.1007/s10067-013-2370-8
dc.identifier.eissn1434-9949
dc.identifier.issn0770-3198
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/7347
dc.language.isoeng
dc.publisherSPRINGER LONDON LTD
dc.relation.ispartofClinical Rheumatology
dc.rightsrestrictedAccess
dc.rights.holderCopyright SPRINGER LONDON LTD
dc.subjectHealth Assessment Questionnaire
dc.subjectQuality of life
dc.subjectSF-36
dc.subjectSystemic sclerosis
dc.subject.otherquality-of-life
dc.subject.othersystemic-sclerosis
dc.subject.otherdisability index
dc.subject.othermedical outcomes
dc.subject.othersf-36
dc.subject.otherclassification
dc.subject.otherdiseases
dc.subject.otherability
dc.subject.otherscales
dc.subject.othertrial
dc.subject.wosRheumatology
dc.titleCross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoca
hcfmusp.author.externalMARANGONI, Roberta G.:Northwestern Univ, Div Rheumatol, Chicago, IL 60611 USA
hcfmusp.author.externalSTEEN, Virginia:Georgetown Univ, Div Rheumatol, Washington, DC 20007 USA
hcfmusp.author.externalKOWALSKI, Sergio C.:McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada
hcfmusp.citation.scopus8
hcfmusp.contributor.author-fmusphcLUIZA FUOCO DA ROCHA
hcfmusp.contributor.author-fmusphcPERCIVAL DEGRAVA SAMPAIO BARROS
hcfmusp.contributor.author-fmusphcMAURICIO LEVY NETO
hcfmusp.contributor.author-fmusphcNATALINO HAJIME YOSHINARI
hcfmusp.contributor.author-fmusphcELOISA SILVA DUTRA DE OLIVEIRA BONFA
hcfmusp.description.beginpage699
hcfmusp.description.endpage706
hcfmusp.description.issue5
hcfmusp.description.volume33
hcfmusp.origemWOS
hcfmusp.origem.pubmed23975361
hcfmusp.origem.scopus2-s2.0-84902363299
hcfmusp.origem.wosWOS:000335401500016
hcfmusp.publisher.cityLONDON
hcfmusp.publisher.countryENGLAND
hcfmusp.relation.referenceCHACKO KA, 1995, CIRCULATION, V92, P2003
hcfmusp.relation.referenceCharles C, 2006, LANCET, V367, P1683, DOI 10.1016/S0140-6736(06)68737-0
hcfmusp.relation.referenceCiconelli R.M., 1999, REV BRAS REUMATOL, V39, P143
hcfmusp.relation.referenceClements PJ, 2001, ARTHRITIS RHEUM, V44, P653, DOI 10.1002/1529-0131(200103)44:3<653::AID-ANR114>3.0.CO;2-Q
hcfmusp.relation.referenceClements Philip J., 1995, Current Opinion in Rheumatology, V7, P517
hcfmusp.relation.referenceCohen J, 2003, APPL MULTIPLE REGRES, P703
hcfmusp.relation.referenceDanieli E, 2005, CLIN RHEUMATOL, V24, P48, DOI 10.1007/s10067-004-0970-z
hcfmusp.relation.referenceFERRAZ MB, 1990, J RHEUMATOL, V17, P813
hcfmusp.relation.referenceFRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202
hcfmusp.relation.referenceFRIES JF, 1982, J RHEUMATOL, V9, P789
hcfmusp.relation.referenceGeorges C, 2005, CLIN RHEUMATOL, V24, P3, DOI 10.1007/s10067-004-0942-3
hcfmusp.relation.referenceHudson M, 2009, J RHEUMATOL, V36, P1226, DOI 10.3899/jrheum.081057
hcfmusp.relation.referenceHudson M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1112, DOI 10.1002/art.24676
hcfmusp.relation.referenceJohnson SR, 2005, ARTHRIT RHEUM-ARTHR, V53, P256, DOI 10.1002/art.21084
hcfmusp.relation.referenceKhanna D, 2005, J RHEUMATOL, V32, P832
hcfmusp.relation.referenceKhanna D, 2007, ARTHRITIS RHEUM, V56, P1676, DOI 10.1002/art.22580
hcfmusp.relation.referenceKuwana M, 2003, J RHEUMATOL, V30, P1253
hcfmusp.relation.referenceLa Montagna G, 2006, Reumatismo, V58, P112
hcfmusp.relation.referenceLaguardia J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-61
hcfmusp.relation.referenceLEROY EC, 1988, J RHEUMATOL, V15, P202
hcfmusp.relation.referenceOstojic P, 2006, Z RHEUMATOL, V65, P168, DOI 10.1007/s00393-006-0050-7
hcfmusp.relation.referencePope J, 2011, ARTHRIT CARE RES, V63, pS98, DOI 10.1002/acr.20598
hcfmusp.relation.referenceRamos-Casals M, 2010, NAT REV RHEUMATOL, V6, P269, DOI 10.1038/nrrheum.2010.48
hcfmusp.relation.referenceRannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P94, DOI 10.1002/art.22468
hcfmusp.relation.referenceRuof J, 1999, RHEUMATOLOGY, V38, P535, DOI 10.1093/rheumatology/38.6.535
hcfmusp.relation.referenceSilman A, 1998, J RHEUMATOL, V25, P79
hcfmusp.relation.referenceSmyth AE, 2003, RHEUMATOLOGY, V42, P732, DOI 10.1093/rheumatology/keg145
hcfmusp.relation.referencePoole J L, 1991, Arthritis Care Res, V4, P27, DOI 10.1002/art.1790040106
hcfmusp.relation.referenceSteen VD, 1997, ARTHRITIS RHEUM, V40, P1984, DOI 10.1002/art.1780401110
hcfmusp.relation.referenceTektonidou MG, 2011, NAT REV RHEUMATOL, V7, P708, DOI 10.1038/nrrheum.2011.157
hcfmusp.relation.referenceTerwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012
hcfmusp.relation.referenceWare J. E., 2000, SF 36 HLTH SURVEY MA
hcfmusp.relation.referenceWARE JE, 1995, MED CARE, V33, pAS264
hcfmusp.relation.referenceWild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationcd206634-f3db-4a88-bb5c-bcbf9a3e0696
relation.isAuthorOfPublication543b5865-d037-4c2e-8a6b-28f77f9e9e8e
relation.isAuthorOfPublicationc21fc5dc-22d3-4437-a429-2bf6c5703a17
relation.isAuthorOfPublication2e21c7d3-7217-46d9-94d7-e5ed467e6955
relation.isAuthorOfPublication708e64de-56af-4523-b920-b237f71535b2
relation.isAuthorOfPublication.latestForDiscoverycd206634-f3db-4a88-bb5c-bcbf9a3e0696
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_ROCHA_Cross_cultural_adaptation_and_validation_of_the_Brazilian_2014.PDF
Tamanho:
202.76 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)